What is Lamicdin used for?
Lamicdin is an anticonvulsant drug used as monotherapy and adjunctive treatment of partial seizures and primary and secondary generalized tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome. Lamicdin is also used off-label for maintenance therapy of bipolar I disorder.
How much and how often should Lamicdin be taken?
For monotherapy and adjunctive treatment of seizures in adults: Monotherapy: initial dose of 25 mg once daily for 2 weeks, followed by 50 mg once daily for 2 weeks, thereafter, dose is increased by a maximum of 50 mg to 100 mg every 1 to 2 weeks. Maintenance dose is 100 mg to 200 mg daily.
For bipolar disorder, dose is 100 mg to 200 mg daily.
What are possible side effects of Lamicdin?
Some of the possible side effects of Lamicdin include skin rashes, Stevens-Johnson Syndrome (SJS), fever, malaise, flu-like symptoms, drowsiness, lymphadenopathy, facial edema, rarely hepatic dysfunction, leukopenia, and thrombocytopenia.
What is the available pack size of Lamicdin?
Lamicdin is Lamotrigine 50 mg tablet available in blister pack of 10’s in box of 30’s and 100 mg tablet available in blister pack of 10’s in box of 30’s.
FDA Registration number
50 mg: DRP-3340-03
100 mg: DRP-3283-02